Rare
lephants
Screener
Toggle theme
VERICEL CORPORATION
VCEL
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$73.9M
Line Item
Value
% of Total
Capital Expenditures
$0
0.0%
Other Investing
$0
0.0%
Working Capital
$14.9M
20.2%
Other
$43.9M
59.5%
Net Cash Flow
$15.0M
20.4%
Download CSV
